Cargando…
Overexpression of HMGB3 and its prognostic value in breast cancer
BACKGROUND: High mobility group protein B3 (HMGB3) is abundantly expressed in a number of malignancies, contributing to tumor cell growth and predicting poor outcomes. More research on the connection between HMGB3 and breast cancer is needed. The prognostic significance of HMGB3 in breast cancer was...
Autores principales: | Zhou, Xiaomei, Zhang, Qu, Liang, Gai, Liang, Xinjun, Luo, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815698/ https://www.ncbi.nlm.nih.gov/pubmed/36620553 http://dx.doi.org/10.3389/fonc.2022.1048921 |
Ejemplares similares
-
Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
por: Bao, Guoqiang, et al.
Publicado: (2010) -
Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022) -
Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022) -
Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer
por: Liu, Yanyan, et al.
Publicado: (2020) -
The Prognostic Value of New Index (LANR) Composed of Pre-operative Lymphocytes, Albumin, and Neutrophils in Patients With Resectable Colorectal Cancer
por: Liang, Xinjun, et al.
Publicado: (2021)